The Cr (VI) bioreduction has attracted widespread attention in the field of Cr (VI) pollution
remediation due to its environmental friendliness. Further in-depth research on the reduction …

Aim: This study uses network pharmacology to design a c-Src inhibitor followed by
pharmacophore modeling to combat glioblastoma multiforme. These in silico approaches …

Introduction: Vitiligo, a common autoimmune acquired pigmentary skin disorder, poses
challenges due to its unclear pathogenesis. Evidence suggests inflammation and …

Introduction: Osteosarcoma (OS) is the most prevalent kind of bone cancer, but the
tumorigenesis and underlying molecular drivers of OS remain unknown. The instability of the …

The aim of this study was to identify potential high-frequency mutation (HFM) genes and
associated molecular mechanisms during the progression of thyroid cancer (TC). The …

One of the biggest threats to public health in the 21st century is antimicrobial resistance
(AMR), which happens when bacteria change and make antibiotics that treat infections less …

Objective. This study is aimed at screening out effective active compounds of Qizhen
capsule (QZC) and exploring the underlying mechanisms against gastric cancer (GACA) by …

Precision medicine utilizes pharmacogenomic testing as a therapeutic approach. Genomic
testing can assess the impact of an individual's genome on their reaction to specific …

The third most prevalent cancer diagnosed worldwide is colorectal cancer, which usually
develops in adults over 50 ages.[1] In this study, we aimed to explore novel drug-target …

Glioblastoma is one of the most debilitating forms of brain tumour. It accounts for 17% of all
the brain tumours and has resulted in 251,329 deaths in 2020 itself. Several studies …